Entelos Inc. (ENTL.LN), which makes software that lets pharmaceutical companies run "virtual" drug trials using computers, said Wednesday it signed a research deal with GlaxoSmithKline PLC (GSK.LN).

GlaxoSmithKline wants to use Entelos' Hematopoeisis PhysioLab platform to develop drugs for anemia.

Financial terms weren't disclosed.

Company Web site: www.entelos.com

-By Jason Douglas, Dow Jones Newswires; 44-20-7842-9272; jason.douglas@dowjones.com

Click here to go to Dow Jones NewsPlus, a web front page of today's most important business and market news, analysis and commentary. You can use this link on the day this article is published and the following day.
Entelos Regs (LSE:ENTL)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more Entelos Regs Charts.
Entelos Regs (LSE:ENTL)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more Entelos Regs Charts.